Srikara Parenterals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 7.98 Cr
as on 08-07-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 9.28 Cr
as on 08-07-2024
- Revenue -30.02%
(FY 2015)
- Profit -5.96%
(FY 2015)
- Ebitda -0.18%
(FY 2015)
- Net Worth 12.93%
(FY 2015)
- Total Assets 3.39%
(FY 2015)
About Srikara Parenterals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.98 Cr.
The company currently has active open charges totaling ₹9.28 Cr.
Naga Gorla, Sri Gorla, Prem Rayepudi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24244AP2005PTC045974
- Company No.
045974
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2005
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Srikara Parenterals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naga Gorla  | Managing Director | 25-Apr-2005 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sri Gorla | Director | 25-Apr-2005 | Current |
| Prem Rayepudi | Director | 01-Sep-2011 | Current |
| Gorla Krishna | Director | 01-Sep-2011 | Current |
Financial Performance of Srikara Parenterals.
Srikara Parenterals Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 30.02% decrease. The company also saw a slight decrease in profitability, with a 5.96% decrease in profit. The company's net worth Soared by an impressive increase of 12.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srikara Parenterals?
In 2015, Srikara Parenterals had a promoter holding of 24.13% and a public holding of 75.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 09 Jan 2005 | ₹9.28 Cr | Open |
How Many Employees Work at Srikara Parenterals?
Srikara Parenterals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srikara Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srikara Parenterals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
